Strategic report Governance & remuneration Financial statements Investor information Financial record continued Five year record A record of financial performance is provided, analysed in accordance with current reporting practice.
The information included in the Five year record is prepared in accordance with IFRS as adopted by the European Union and also with IFRS as issued by the International Accounting Standards Board.
The Established Products segment has been created and certain product reclassications, principally the OTC dermatology brands acquired with the Stiefel business, have been made between Pharmaceuticals and Vaccines segments and the Consumer Healthcare segment, with effect from 1 January 2014.
Comparative turnover information in all four years has been restated accordingly.
In addition, the 2013 and 2012 core results have been restated to exclude the divestments completed in 2013.
Comparative information for 2012 is also reported including the effect of the divestments completed in 2013.
The number of employees is the number of permanent employed staff at the end of the financial period.
It excludes those employees who are employed and managed by GSK on a contract basis.
Exchange rates As a guide to holders of ADS, the following tables set out, for the periods indicated, information on the exchange rate of US dollars for Sterling as reported by the Bank of England 4pm buying rate.
2014 2013 2012 2011 2010 Average 1.65 1.56 1.59 1.60 1.55 The average rate for the year is calculated as the average of the 4pm buying rates for each day of the year.
